Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Open | $4.30 |
Close | $4.22 |
Volume / Avg. | 4.84M / 2.27M |
Day Range | $4.03 - $4.35 |
52 Wk Range | 2.83 - 23.12 |
Market Cap | $295.81M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 34.85% |
Days to Cover | 16.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zentalis Pharma (NASDAQ:ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR) and PepGen (NASDAQ:PEPG).
There is no analysis for Zentalis Pharma to provide a consensus price target.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $4.16 last updated September 20, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.